title: Serum proteomic profiling of dementia with Lewy bodies: diagnostic potential of SELDI-TOF MS analysis.
abstract: Dementia with Lewy bodies (DLB) is the second most common senile degenerative dementia after Alzheimer's disease (AD). The presentation of overlapping symptoms between these two disorders leads to difficulties in the determination of clinical entities. Serum samples were subjected to surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) analysis in order to identify a diagnostic marker for DLB. Four putative protein peaks (m/z 3,883, 4,964, 7,761 and 10,534) were differentially expressed in DLB patients compared to AD patients and control subjects. Receiver operating characteristics (ROC) analysis of a multivariate logistic model of the combination of three peaks (m/z 3,883, 7,761 and 10,534) exhibited the highest discriminatory ability of DLB subjects from non-DLB subjects with a sensitivity of 83.3%, a specificity of 95.8%, a positive predictive value of 90.9% and a negative predictive value of 92.0%. SELDI-TOF MS profiling, therefore, has revealed a serum signature with high diagnostic potential for DLB.
authors: Department of Neurology, Faculty of Medicine, Institute of Neurological Sciences, Tottori University, Yonago, Japan. kewada@grape.med.tottori-u.ac.jp
authors: K
authors: K
authors: Wada-Isoe
authors: K
authors: K
authors: Michio
authors: K
authors: K
authors: Imamura
authors: K
authors: K
authors: Nakaso
authors: M
authors: M
authors: Kusumi
authors: H
authors: H
authors: Kowa
authors: K
authors: K
authors: Nakashima
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood*; D005260:Female; D006801:Humans; D020961:Lewy Body Disease / Q000097:blood* / Q000175:diagnosis*; D008297:Male; D040081:Protein Array Analysis; D040901:Proteomics / Q000379:methods*; D012372:ROC Curve; D012680:Sensitivity and Specificity; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
chemical_list: D015415:Biomarkers
references: Arthritis Rheum. 2005 Dec;52(12):3801-12
references: 16320331
references: Ann Neurol. 2001 Sep;50(3):358-65
references: 11558792
references: Clin Neurol Neurosurg. 2005 Aug;107(5):396-403
references: 16023534
references: Neurobiol Aging. 2002 May-Jun;23(3):363-70
references: 11959397
references: J Neurol Neurosurg Psychiatry. 2001 Nov;71(5):583-8
references: 11606666
references: J Infect Dis. 2006 Nov 15;194(10):1356-66
references: 17054064
references: Neurology. 2006 Apr 25;66(8):1218-22
references: 16481598
references: Lancet Neurol. 2006 Mar;5(3):228-34
references: 16488378
references: Lancet Neurol. 2004 Jan;3(1):19-28
references: 14693108
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 15;849(1-2):105-14
references: 17097359
references: Proteomics. 2006 Dec;6(24):6405-15
references: 17096316
references: Trends Pharmacol Sci. 2006 May;27(5):251-9
references: 16600386
references: Neurosci Lett. 2004 Nov 3;370(1):36-9
references: 15489013
references: Neurology. 1984 Jul;34(7):939-44
references: 6610841
references: Arch Neurol. 2004 Jun;61(6):919-25
references: 15210531
references: Neurology. 2005 Dec 27;65(12):1863-72
references: 16237129